No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis.
Journal
NPJ schizophrenia
ISSN: 2334-265X
Titre abrégé: NPJ Schizophr
Pays: United States
ID NLM: 101657919
Informations de publication
Date de publication:
21 Sep 2021
21 Sep 2021
Historique:
received:
12
04
2021
accepted:
26
08
2021
entrez:
22
9
2021
pubmed:
23
9
2021
medline:
23
9
2021
Statut:
epublish
Résumé
Cognitive impairment is an important predictor of disability in schizophrenia. Dopamine neurotransmission in cortical brain regions has been suggested to be of importance for higher-order cognitive processes. The aim of this study was to examine the relationship between extrastriatal dopamine D2-R availability and cognitive function, using positron emission tomography and the high-affinity D2-R radioligand [
Identifiants
pubmed: 34548499
doi: 10.1038/s41537-021-00176-x
pii: 10.1038/s41537-021-00176-x
pmc: PMC8455597
doi:
Types de publication
Journal Article
Langues
eng
Pagination
46Subventions
Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 2017-00875
Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 09114
Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 523-2014-3467
Informations de copyright
© 2021. The Author(s).
Références
Am J Psychiatry. 2008 Feb;165(2):214-20
pubmed: 18172018
Eur J Clin Pharmacol. 2014 Feb;70(2):127-34
pubmed: 24145817
Schizophr Bull. 2019 Apr 25;45(3):670-679
pubmed: 29878197
Arch Gen Psychiatry. 1988 Jan;45(1):71-6
pubmed: 2892477
EJNMMI Res. 2020 Jul 8;10(1):77
pubmed: 32642865
J Exp Psychol. 1948 Aug;38(4):404-11
pubmed: 18874598
Schizophr Bull. 1993;19(2):233-59
pubmed: 8322034
JAMA Psychiatry. 2015 Apr;72(4):316-24
pubmed: 25651194
J Int Neuropsychol Soc. 2008 Jan;14(1):110-8
pubmed: 18078537
Front Psychiatry. 2014 Jan 08;4:182
pubmed: 24409157
J Clin Exp Neuropsychol. 2012;34(6):667-77
pubmed: 22439943
Psychiatry Res. 2007 Oct 15;156(1):69-74
pubmed: 17683918
J Clin Psychiatry. 2016 Feb;77 Suppl 2:8-11
pubmed: 26919052
Neurosci Biobehav Rev. 2016 Sep;68:979-1000
pubmed: 27344000
Neuropsychology. 1998 Jul;12(3):426-45
pubmed: 9673998
Am J Psychiatry. 2010 Jul;167(7):828-35
pubmed: 20439390
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):502-504
pubmed: 31713656
Biol Psychiatry. 1993 Feb 15;33(4):227-35
pubmed: 8097114
Appl Radiat Isot. 2009 Jan;67(1):106-10
pubmed: 19013077
Psychiatr Clin North Am. 2005 Sep;28(3):613-33, 626
pubmed: 16122570
Transl Psychiatry. 2018 Jan 31;8(1):30
pubmed: 29382821
Am J Psychiatry. 1998 Mar;155(3):344-9
pubmed: 9501743
Brain Imaging Behav. 2016 Mar;10(1):1-11
pubmed: 25749917
Am J Psychiatry. 2009 Jun;166(6):675-82
pubmed: 19369319
Neuroimage. 2010 Jun;51(2):918-22
pubmed: 20188195
Nucl Med Biol. 2000 Oct;27(7):661-70
pubmed: 11091109
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Am J Psychiatry. 2009 Aug;166(8):863-74
pubmed: 19411370
Front Psychol. 2015 Mar 03;6:223
pubmed: 25784889
Front Psychol. 2014 Jul 29;5:781
pubmed: 25120503
Am J Psychiatry. 2008 Feb;165(2):203-13
pubmed: 18172019
Schizophr Res. 2014 Sep;158(1-3):156-62
pubmed: 25086658
Int J Neuropsychopharmacol. 2013 Feb;16(1):23-36
pubmed: 22338593
J Psychopharmacol. 2013 Apr;27(4):374-85
pubmed: 23118022
Schizophr Res. 2013 Oct;150(1):42-50
pubmed: 23911259
Int J Neuropsychopharmacol. 2016 Apr 29;19(5):
pubmed: 26819282
Neuroimage. 2012 Mar;60(1):800-7
pubmed: 22227138
Psychopharmacology (Berl). 2018 Aug;235(8):2221-2232
pubmed: 29717334
Schizophr Res. 2018 Feb;192:442-456
pubmed: 28576546
Neuroimage. 2007 Feb 15;34(4):1643-9
pubmed: 17174573
Front Psychiatry. 2018 Dec 05;9:622
pubmed: 30568606
Schizophr Bull. 2009 Jan;35(1):19-31
pubmed: 19042912
J Neurosci. 2008 Nov 12;28(46):12032-8
pubmed: 19005068
Am J Psychiatry. 2000 Apr;157(4):635-7
pubmed: 10739428
Neuroimage. 2004 Jun;22(2):794-803
pubmed: 15193608
Arch Gen Psychiatry. 2012 Aug;69(8):776-86
pubmed: 22474070
Psychol Med. 2019 May;49(7):1138-1147
pubmed: 30058511
Neuroimage. 2008 Apr 15;40(3):1287-95
pubmed: 18296072